TickerStat.com

Protalix BioTherapeutics, Inc. (PLX)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$52.7M$53.4M$65.5M$47.6M$38.4M$62.9M$54.7M$34.2M$21.1M$9.2M$4.4M$3.5M$10.5M$34.9M$8.4M$6.6M$388,000
Gross profit————————$4.0M$801,000$3.6M$2.9M$6.1M$26.3M$1.4M$6.9M−$3.2M
Research & development$19.6M$13.0M$17.1M$29.3M$29.7M$38.2M$44.6M$33.3M$32.2M$30.4M$24.9M$27.4M$29.2M$36.7M$37.8M$37.7M$27.4M
Operating income−$5.5M$3.9M$10.5M−$13.0M−$20.5M$2.7M−$10.7M−$19.3M−$34.5M−$33.2M−$23.7M−$28.6M−$34.1M−$12.2M−$36.5M−$30.0M−$32.0M
Net income−$6.6M$2.9M$8.3M−$14.9M−$27.6M−$6.5M−$18.3M−$26.5M−$83.4M−$29.4M$58.0M−$29.9M−$27.8M−$11.6M−$36.5M−$29.0M−$31.4M
Basic EPSper diluted share-$0.08$0.04$0.12-$0.31-$0.62-$0.22-$1.23-$1.80-$6.37-$0.29$0.61-$0.32-$0.30-$0.13-$0.43-$0.36$0.41
Diluted EPSper diluted share-$0.08$0.04$0.09-$0.31-$0.62-$0.22-$1.23-$1.80-$6.37-$0.29$0.61-$0.32-$0.30-$0.13-$0.43-$0.36$0.41
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys2$307.8K disclosed value
Sells (SEC code S)1$314.16 disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 19, 2025Form 4Bashan DrorPRESIDENT AND CEOBuyCommon Stock56.0K$1.81$101.4K188.5K
Nov 18, 2025Form 4Bar-Shalev AmosDirectorSellCommon Stock168$1.87$314.160
Jun 10, 2025Form 4Schwartz AharonDirectorBuyCommon Stock129.0K$1.60$206.4K303.0K
Review ownership filings at SEC.gov ↗